27.01.2014 Views

IMS LifeLink PharMetrics Plus™ – U.S. - IMS Health

IMS LifeLink PharMetrics Plus™ – U.S. - IMS Health

IMS LifeLink PharMetrics Plus™ – U.S. - IMS Health

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

GLOBAL PATIENT-CENTERED ANALYTICS AND SERVICES<br />

<strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus – U.S.<br />

Real World Evidence. Real World Impact.<br />

<strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus brings you<br />

details on the real-world treatment experience<br />

and health outcomes of more than 150 million<br />

unique patients.<br />

<strong>IMS</strong> <strong>Health</strong> introduces <strong>LifeLink</strong><br />

<strong>PharMetrics</strong> Plus, the largest,<br />

most comprehensive database<br />

of integrated medical claims in<br />

the United States. The depth<br />

and breadth of the coverage<br />

provides new patient- and<br />

physician-level insights.<br />

Key Information Types<br />

• Diagnoses and Procedures<br />

• Retail and Mail Order Prescriptions<br />

• Inpatient details—Admitting Diagnosis,<br />

Admission Source & Type<br />

• Provider/Pharmacy ID<br />

• Pharmacy Benefit Design—Co-pay/<br />

Coinsurance Amount; Deductible Amount<br />

• Costs of Services and Prescriptions<br />

• Place of Service<br />

• Plan Type and Time Enrolled<br />

RWEinfo@imshealth.com<br />

+1 (703) 837 5150<br />

www.imshealth.com/rwe<br />

NEW INSIGHTS<br />

As global market dynamics have placed increasing importance<br />

on evidence that proves the value of health technologies, the<br />

demand for HEOR guidance has grown. Yet, historical challenges<br />

stemming from the quality of data, gaps between data sets,<br />

and the need for specialized technical skills have remained.<br />

To power your research more effectively, <strong>IMS</strong> brings you <strong>IMS</strong><br />

<strong>LifeLink</strong> <strong>PharMetrics</strong> Plus with health plan claims information<br />

on 150 million de-identified lives in the U.S.—all in a single,<br />

database. Rich details down to the three-digit ZIP Code level<br />

and from 2006 onward include:<br />

• Diagnosis, procedures and prescriptions spanning all<br />

therapy areas<br />

• Provider identities for billing, rendering and attending<br />

physicians across all healthcare settings<br />

• Insurance provisions such as co-pays and deductibles<br />

The depth and breadth of this coverage allows you to study<br />

sub-populations of patients, while streamlining your costs for<br />

claims data. Because we de-identify the data at the patient<br />

level using <strong>IMS</strong>’ patented technology, you can integrate<br />

<strong>PharMetrics</strong> Plus with other <strong>IMS</strong> databases or with your own<br />

patient-level data sets for research.<br />

A TRUSTED SOURCE<br />

Through an agreement with <strong>Health</strong> Intelligence Company LLC,<br />

<strong>IMS</strong> has exclusive rights to the organization's healthcare claims<br />

database for use in the biopharmaceutical market. The data<br />

are amassed from the member plans within HIC, the operating<br />

arm of Blue <strong>Health</strong> Intelligence, and comingled with <strong>IMS</strong> data<br />

from various sources throughout the U.S., including commercial<br />

health and managed care plans.<br />

Our four-step certification and quality-control process<br />

ensures that the data meet our exacting standards and are<br />

HIPAA compliant.<br />

<strong>IMS</strong> HEALTH | 1725 DUKE STREET, SUITE 510, ALEXANDRIA, VA 22314, USA


GLOBAL PATIENT-CENTERED ANALYTICS AND SERVICES<br />

<strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus – U.S.<br />

ENABLING RIGOROUS ANALYTICS<br />

With the granularity that such a comprehensive dataset provides, <strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong><br />

Plus serves as the foundation for:<br />

• HEOR studies that measure the comprehensive Burden of Illness across settings of care,<br />

Total Cost of Care, Patient Treatment Patterns, Adherence and Persistence to Treatment,<br />

Disease Incidence, Prevalence and Safety<br />

• Market Access initiatives such as Value Preparation and HTA readiness<br />

• Commercial activities that rely on an understanding of the patient experience, including<br />

Adherence & Compliance programs, Segmentation exercises (provider and patient) and<br />

Patient Flow mapping<br />

COMPATIBILITY ACROSS PATIENT-LEVEL DATA SOURCES<br />

Because we de-identify the data at the patient level, <strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus:<br />

• Is compatible with a range of supplemental, proprietary <strong>LifeLink</strong> data assets including<br />

EMR,Longitudinal Prescription, and Demographic sets encompassing more than 240 million<br />

U.S. patients<br />

• Through <strong>IMS</strong> customized solutions, can be integrated with other traditionally disparate<br />

data sets including internal data (e.g., RCT), <strong>IMS</strong> data, and additional third-party data<br />

• Through de-identification technology, <strong>PharMetrics</strong> Plus and other <strong>IMS</strong> assets are<br />

scalable over time as new data sources are acquired to close gaps at the therapeutic<br />

level and beyond<br />

COMPREHENSIVE SUPPORT<br />

Our focus extends beyond data solutions by providing comprehensive tools and support services<br />

and investing in technologies that support your current and future global needs. We offer:<br />

• Technology solutions to provide efficient interrogation of the data, including structured<br />

analytic, visualization and reporting features.<br />

• A team of more than 200 HEOR staff members across 18 countries who are available to<br />

help you analyze, interpret and communicate your research results.<br />

• Global partnerships including a collaboration with the UK’s National <strong>Health</strong> Service<br />

observational data and interventional research service, Clinical Practice Research Datalink.<br />

2011 SAMPLE COUNTS FOR PATIENTS WITH MEDICAL AND PHARMACY COVERAGE<br />

>4.5 million<br />

patients<br />

>1.3 million<br />

patients<br />

250 thousand<br />

patients<br />

Hypertension Asthma Breast Cancer<br />

With the richness of insights available in <strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus, <strong>IMS</strong> is leading<br />

the way to a greater understanding of the value of medical technologies—and more<br />

productive dialogues with a range of healthcare stakeholders.<br />

To find out more about the way that <strong>IMS</strong> can help you benefit from comprehensive<br />

patient-level information, please email RWEinfo@imshealth.com<br />

<strong>IMS</strong> HEALTH | 1725 DUKE STREET, SUITE 510, ALEXANDRIA, VA 22314, USA<br />

© 2012 <strong>IMS</strong> <strong>Health</strong> Incorporated and its affiliates. All rights reserved.<br />

Trademarks are registered in the United States and in various other countries.<br />

HEORPM1012

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!